supercritical fluid technology
Adjust Font Size: Decrease Increase

Micell's supercritical fluid technology (SCF) provides several unique advantages in the modification and coating of biomedical surfaces with advanced polymers and drugs. Compared to current solvent-based coating systems, Micell's technology for creating drug-eluting coatings is:

Dry - Meaning that polymers, drugs and medical devices are not exposed to conventional liquid solvents.

Cool - Our processes function at moderate temperatures to preserve the structure and morphology of therapeutic agents.

Flexible - By combining electrostatic attraction with supercritical fluids, Micell can create surface modifications for a broad range of medical devices using a variety of polymers and drugs.

The supercritical fluid process allows the use of therapeutic agents that may be sensitive to elevated temperatures or traditional solvent processes. Most existing coating processes for medical devices involve an organic solvent that may alter the chemistry of the therapeutic agent or affect human health. Micell's SCF-based methods - which are completely solvent-free - avoid the challenges associated with the use of common solvents and offer opportunities for significant and rapid process advantages.

Caution: The MiStent SES has received CE marking but is not approved in the USA or any other countries. Any other products described on this website are investigational devices that are not available for sale in any country.
Home | About Us | Therapeutic Focus | Product Pipeline | Technology | News | Terms of Use | Privacy Policy | Site Map
© 2014 Micell Technologies, Inc. All rights reserved.
"Micell", "MiStent", and "MiStent SES" are registered trademarks of Micell Technologies, Inc.